BL&H Co Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:BL&H Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10846
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BL&H Co Ltd (BL&H), a subsidiary of STADA Pharmaceuticals (Asia) Ltd is a drug company that manufactures and markets diagnostic test kits and drugs. The company offers products including aridol bronchial challenge test kit, cetraxal plus ear drop, al-sense amniotic leak test kit, DC bead-drug eluting beads, Lung Flute, OTC products, and ETC products. It provides products such as metoject, microshield, microshield antimicrobial hand gel, mutaflor cap, mutaflor sus, orfadin cap., sweatrol pad solution, trisenox inj. and others. BL&H’s products are used for the treatment of acute external otitis and rheumatoid arthritis; prevention of arteriosclerosis; and diagnosis of hereditary tyrosinemia type 1. The company has its presence in the US and Korea. BL&H is headquartered in Seoul, South Korea.

BL&H Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BL&H Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BL&H Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Theratechnologies Enters into Commercialization Agreement with BL&H 11
Licensing Agreements 12
BL&H Enters into Licensing Agreement with Race Oncology 12
BL&H Enter into Licensing Agreement with MDNA Life Sciences 13
BL&H Enters into Licensing Agreement with Telesta Therapeutics 14
Clinigen Enters Into Licensing Agreement With BL&H For Foscavir 15
Equity Offering 16
Telesta Therapeutics Raises USD0.2 Million in Private Placement of Shares 16
BL&H Co Ltd – Key Competitors 17
BL&H Co Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
BL&H Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BL&H Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BL&H Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
BL&H Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Theratechnologies Enters into Commercialization Agreement with BL&H 11
BL&H Enters into Licensing Agreement with Race Oncology 12
BL&H Enter into Licensing Agreement with MDNA Life Sciences 13
BL&H Enters into Licensing Agreement with Telesta Therapeutics 14
Clinigen Enters Into Licensing Agreement With BL&H For Foscavir 15
Telesta Therapeutics Raises USD0.2 Million in Private Placement of Shares 16
BL&H Co Ltd, Key Competitors 17
BL&H Co Ltd, Other Locations 18

List of Figures
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BL&H Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[BL&H Co Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Animalcare Group Plc (ANCR):企業の財務・戦略的SWOT分析
    Summary Animalcare Group Plc (Animalcare) is a animal healthcare service provider that develops and supplies veterinary medicines and services. The company offers products such as licensed veterinary medicines, companion animal identification and animal welfare products. It offers its product to dog …
  • Heartland Group Holdings Ltd (HGH):企業の財務・戦略的SWOT分析
    Heartland Group Holdings Ltd (HGH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Datatec Limited:企業の戦略・SWOT・財務分析
    Datatec Limited - Strategy, SWOT and Corporate Finance Report Summary Datatec Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • McAfee, Inc.:企業の戦略的SWOT分析
    McAfee, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Arno Therapeutics Inc (ARNI)-製薬・医療分野:企業M&A・提携分析
    Summary Arno Therapeutics Inc (Arno) is a clinical stage biopharmaceutical company that develops products for the treatment of cancer, infectious diseases and other life threatening diseases. The company has exclusive worldwide rights for the development and commercialization of Onapristone (for the …
  • Sing Investments & Finance Limited (S35):企業の財務・戦略的SWOT分析
    Sing Investments & Finance Limited (S35) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Ontario Municipal Employees Retirement System-エネルギー分野:企業M&A・提携分析
    Summary Ontario Municipal Employees Retirement System (OMERS) offers pension benefits to government employees, beneficiaries, and retirees from diverse sectors such as municipalities, libraries, police and fire departments, schools, and other agencies in Ontario. It is governed by OMERS Sponsors Cor …
  • Intertape Polymer Group Inc (ITP):企業の財務・戦略的SWOT分析
    Intertape Polymer Group Inc (ITP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Sunstone Hotel Investors, Inc.:企業のM&A・事業提携・投資動向
    Sunstone Hotel Investors, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sunstone Hotel Investors, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Croma-Pharma GmbH-医療機器分野:企業M&A・提携分析
    Summary Croma-Pharma GmbH (Croma Pharma) is a pharmaceutical company which focuses on the development and commercialization of drugs in the field of aesthetic dermatology. It offers princess injectables, princess skincare, and princess lift products. The company’s princess skincare products comprise …
  • Greencore Group Plc:企業のM&A・事業提携・投資動向
    Greencore Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Greencore Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Kalgene Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Kalgene Pharmaceuticals Inc (Kalgene Pharmaceuticals) is a pre-clinical stage biotechnology company focused on the development of novel fusion protein therapeutic's for the treatment of neurodegenerative diseases. Its lead product candidate KAL-ABP, targets toxic amyloid beta oligomers that …
  • Trimedyne Inc:企業の戦略的SWOT分析
    Trimedyne Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • China Gas Holdings Ltd (384):石油・ガス:M&Aディール及び事業提携情報
    Summary China Gas Holdings Ltd (CGHL) is a gas operator and service provider. The company offers piped natural gas, compressed natural gas, liquid petroleum gas and liquefied natural gas. Its activities include construction and operation of gas stations, gas pipeline infrastructure facilities, gas t …
  • Eutelsat Communications Group:企業の戦略・SWOT・財務分析
    Eutelsat Communications Group - Strategy, SWOT and Corporate Finance Report Summary Eutelsat Communications Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Sejal Glass Limited (SEZAL):企業の財務・戦略的SWOT分析
    Sejal Glass Limited (SEZAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • ATUM-製薬・医療分野:企業M&A・提携分析
    Summary ATUM, formerly DNA2.0 Inc is a bioengineering company that provide platforms for protein and vector engineering solutions. The company develops and offers synthetic biology solutions. Its products include expression vectors, electra system, CRISPR/Cas9, proteinpaintbox, cell strains and reag …
  • New China Life Insurance Company Ltd.:企業の戦略・SWOT・財務情報
    New China Life Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report Summary New China Life Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Korea East-West Power Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Korea East-West Power Co., Ltd. (EWP), subsidiary of Korea Electric Power Corporation, is a state-owned electric utility that generates and supplies electricity. It produces electricity from various sources including coal, oil, liquefied natural gas, mini hydro, and renewable sources such as …
  • Trinity Industries, Inc.:企業の戦略・SWOT・財務情報
    Trinity Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Trinity Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆